Trump administration finalizes Medicare drug pricing rule with limited scope

AI justification

[Auto-resolved by learned corrector: learned-map — A=MINT/B=NEUTRAL -> MINT (human chose this in 93% of 255 past reviews)] Limited-scope rule enables piecemeal reform, normalizing inadequate systemic protections. | While the rule introduces a targeted reduction in drug costs for Medicare beneficiaries, its limited application undermines its potential to address systemic healthcare inequities. The narrow scope risks normalizing piecemeal reforms that fail to ensure universal access to affordable